NNMT is an enzyme that methylates nicotinamide, a key NAD+ precursor, depleting cellular methyl donor pools and influencing both NAD+ availability and broader methylation pathways
A deficiency in B12 can lead to a reduction in red blood cell production, resulting in a condition known as pernicious anemia
Individuals with Weakened Immunity Those with autoimmune conditions or undergoing medical treatments may benefit from extra immune support
Track skin response over time, since pigment changes are gradual
MedVi, on the other hand, offers a more traditional dosing protocol with clinician-directed adjustments based on patient response
2000s: Palatin Technologies modified MT-2's structure to create bremelanotide (PT-141), retaining MC3R/MC4R selectivity for sexual function while reducing MC1R activity (tanning) and improving the pharmacological profile